Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeHealthcare

      Healthcare

      Forecasts Predict $40.82 Million in Sales from OraSure Technologies, Inc.
      Health

      Forecasts Predict $40.82 Million in Sales from OraSure Technologies, Inc.

      September 26, 2017
      Stock Rating for OraSure Technologies, Inc. lowered by Zacks Investment Research
      Health

      Stock Rating for OraSure Technologies, Inc. lowered by Zacks Investment Research

      September 25, 2017
      Earnings of -$0.15 Per Share Expected from pSivida Corp.
      Health

      Earnings of -$0.15 Per Share Expected from pSivida Corp.

      September 25, 2017
      Head-to-Head: Spectrum Pharmaceuticals VS PTC Therapeutics
      Health

      Head-to-Head: Spectrum Pharmaceuticals VS PTC Therapeutics

      September 25, 2017
      Analysts Take a Look at Organovo Holdings, Inc
      Healthcare

      Analysts Take a Look at Organovo Holdings, Inc

      September 22, 2017
      Versartis Shares Plunged a Whopping 82% Today
      Health

      Versartis Shares Plunged a Whopping 82% Today

      September 21, 2017
      Intercept Pharmaceuticals Plunged Today, Here’s Why
      Health

      Intercept Pharmaceuticals Plunged Today, Here’s Why

      September 21, 2017
      Iovance Biotherapeutics, Inc. Sets Prices for $50 Million Common Stock Offering
      Biotechnology

      Iovance Biotherapeutics, Inc. Sets Prices for $50 Million Common Stock Offering

      September 21, 2017
      Zacks Investment Research Upgrades VBI Vaccines, Inc.’s Rating
      Biotechnology

      Zacks Investment Research Upgrades VBI Vaccines, Inc.’s Rating

      September 21, 2017
      Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC
      Healthcare

      Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC

      September 21, 2017
      « 1 … 16 17 18 19 20 … 23 »

       

      LATEST NEWS

      • Investing News RPM’s Economic and Weather Challenges
      • Investing News Investment Insights on Top Stocks
      • Investing News Stellantis Reports 68-Year Low in Production
      • Investing News Top Quantum Computing Stocks to Watch
      • Investing News Rivian Achieves 2024 Production Goal

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026